title: Human osteosarcoma expresses specific ephrin profiles: implications for tumorigenicity and prognosis.
abstract: BACKGROUND
  The molecular mechanisms underlying malignancy of osteosarcoma are unknown. It has been reported that eph receptor protein tyrosine kinases and their ligands, ephrins, are associated with increased tumorigenicity in patients with breast carcinoma and melanoma. The expression and role of eph/ephrins in human osteosarcoma has not yet been characterized.
  
  
  METHODS
  Ephrin-A1, ephrin-A3, ephrin-A4, ephrin-A5, ephrin-B1, ephrin-B2, and ephrin-B3 mRNA expression was examined by reverse transcription polymerase chain reaction analysis in nine specimens of human osteosarcoma tissue and five human osteosarcoma cell lines. Ephrin-B1 protein expression was detected immunohistochemically in human osteosarcoma tissue. Clinicopathologic correlation was made between the osteosarcoma specimens and their ephrin expression profiles.
  
  
  RESULTS
  Normal bone specimens, osteosarcoma tissue specimens, and osteosarcoma cell lines expressed a distinct mRNA profile of ephrin-A1, ephrin-A4, and ephrin-B2. A second mRNA profile that included ephrin-A3, ephrin-A5, and ephrin-B1 was expressed by a subset of tumors. The expression of ephrin-B1 was correlated with a poorer clinical prognosis. Ephrin-B1 protein was expressed by osteosarcoma cells and blood vessels.
  
  
  CONCLUSIONS
  The results of this study suggest that ephrin-B1 expressed by osteosarcoma may be a poor prognostic marker through increased tumorigenicity.
authors.affiliation: Department of Orthopedics and Trauma, The Queen Elizabeth Hospital, Woodville, South Australia, Australia.
authors.forename: Antiopi
authors.initials: A
authors.lastname: Varelias
authors.forename: Simon A
authors.initials: SA
authors.lastname: Koblar
authors.forename: Prudence A
authors.initials: PA
authors.lastname: Cowled
authors.forename: Christopher D
authors.initials: CD
authors.lastname: Carter
authors.forename: Mark
authors.initials: M
authors.lastname: Clayer
mesh_terms: D036382:Ephrin-A1; D036384:Ephrin-A3; D036385:Ephrin-A4; D036386:Ephrin-A5; D036387:Ephrin-B1; D036388:Ephrin-B2; D036389:Ephrin-B3; D020869:Gene Expression Profiling; D006801:Humans; D007150:Immunohistochemistry; D008565:Membrane Proteins / Q000032:analysis / Q000378:metabolism*; D012516:Osteosarcoma / Q000378:metabolism*; D011379:Prognosis; D011506:Proteins / Q000378:metabolism; D012333:RNA, Messenger / Q000032:analysis; D020133:Reverse Transcriptase Polymerase Chain Reaction; D014407:Tumor Cells, Cultured
chemical_list: D036382:Ephrin-A1; D036384:Ephrin-A3; D036385:Ephrin-A4; D036386:Ephrin-A5; D036387:Ephrin-B1; D036388:Ephrin-B2; D036389:Ephrin-B3; D008565:Membrane Proteins; D011506:Proteins; D012333:RNA, Messenger